Synlogic to Present Data at the American Association for Cancer Research 2018 Annual Meeting – Markets Insider
|
Synlogic to Present Data at the American Association for Cancer Research 2018 Annual Meeting
Markets Insider Synlogic, Inc., (Nasdaq: SYBX) a clinical-stage drug discovery and development company applying synthetic biology to probiotics to develop novel living medicines, today announced that preclinical data from its immuno-oncology (IO) program will be … |
